[18F]FDG PET/CT in the staging of inflammatory breast cancer: A systematic review

被引：11
|
作者：
van Uden, D. J. P. [1 ]
Prins, M. W. [2 ]
Siesling, S. [3 ]
de Wilt, J. H. W. [4 ]
Blanken-Peeters, C. F. J. M. [5 ]
Aarntzen, E. H. J. G. [6 ]
机构：
[1] Rijnstate Hosp, Dept Surg, Wagnerlaan 55, NL-6815 AD Arnhem, Netherlands
[2] Rijnstate Hosp, Dept Radiol, Wagnerlaan 55, NL-6815 AD Arnhem, Netherlands
[3] Univ Twente, Tech Med Ctr, Dept Hlth Technol & Serv Res, Drienerlolaan 5, NL-7522 NB Enschede, Netherlands
[4] Radboud Univ Nijmegen, Dept Surg Oncol, Med Ctr Nijmegen, Geert Grootepl Zuid 10, NL-6525 GA Nijmegen, Netherlands
[5] Rijnstate Hosp, Dept Surg, Wagnerlaan 55, NL-6815 AD Arnhem, Netherlands
[6] Radboud Univ Nijmegen, Med Ctr, Dept Radiol & Nucl Med, Geert Grootepl Zuid 10, NL-6525 GA Nijmegen, Netherlands
来源：
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY | 2020年 / 151卷
关键词：
Positron emission tomography; Staging; Inflammatory breast cancer; EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHY; F-18-FDG PET/CT; SURVIVAL; DIAGNOSIS; PROGNOSIS; CONSENSUS;
D O I：
10.1016/j.critrevonc.2020.102943
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Up to 78 % of patients with inflammatory breast cancer (IBC) present with axillary lymph node involvement and up to 40 % with distant metastases. Previous studies indicate that 2-deoxy-2-(F-18)fluoro-D-glucose ([F-18]FDG) positron emission tomography/computed tomography (PET/CT) might be used for initial staging in patients with inflammatory breast cancer (IBC). In other cancer types, [F-18]FDG PET/CT has been demonstrated to be a sensitive technique, providing complementary information on locoregional and distant disease to conventional imaging modalities. This systematic review showed that F-18]FDG PET/CT detects additional locoregional lymph node metastases and distant metastases in 10.3 % of patients, that were not detected with standard staging imaging. Compared with conventional imaging procedures, [F-18]FDG PET/CT had better diagnostic performance for detection of locoregional and distant metastases and should standardly be used in the diagnostic work-up of IBC patients.
引用
收藏
页数：8
相关论文
共 50 条
  • [31] [18F]FDG-PET/CT results predict outcome in breast cancer
    Sollini, M.
    Zangheri, B.
    Calabrese, L.
    Di Paolo, M.
    Versari, A.
    Gasparini, M.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S623 - S623
  • [32] Comparison of FLT-(18F) and FDG-(18F) to visualize cancer spread while staging locally advanced breast cancer with PET/CT: preliminary data
    Grahek, D
    Gligorov, J
    Beerblock, K
    Selle, F
    Segura, C
    Chopier, J
    Salem, C
    Antoine, M
    Barranger, E
    Montravers, F
    Gutman, F
    Kerrou, K
    De Beco, V
    Marsault, C
    Lotz, JP
    Uzan, S
    Talbot, JN
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S88 - S88
  • [33] [18F]FDG-PET/MRI in Breast Cancer
    Argalia, G.
    Fringuelli, F. M.
    Biscontini, G.
    Palucci, A.
    Romagnolo, C.
    Cottignoli, C.
    Ercolani, P.
    Simonetti, B. F.
    Gradassi, S. Borgoforte
    Burroni, L.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S475 - S475
  • [34] The Influence of Histological Subtypes and Tumour Grade on the Performance of [18F]FDG-PET/CT and [18F] FES-PET/CT in Staging Patients with Estrogen Receptor Positive Breast Cancer
    Knip, J. J.
    Iqbal, R.
    van Zweeden, A.
    Mammatas, L. H.
    Teunissen, J. J. M.
    van der Velde, S.
    Barbe, E.
    Duvivier, K. M.
    Oprea-Lager, D. E.
    Windhorst, A. D.
    Boellaard, R.
    van Oordt, C. W. Menke-van der Houven
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S34 - S34
  • [35] Impact of 18-F FDG PET/CT on staging of locally advanced breast cancer
    Rashki, M.
    Sanchez Sanchez, R.
    Gonzalez Jimenez, A.
    Rebollo Aguirre, A.
    Culianez Casas, M.
    Menjon Beltran, S.
    LLamas Elvira, J.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S461 - S461
  • [36] Assessing the Usefulness of 18F-FDG PET/CT in Staging Primary Breast Cancer
    Escabias, C.
    Santos, I.
    Coronado, M.
    Mendez, R.
    Hernandez, I.
    Coya, J.
    Martin-Curto, L.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S231 - S231
  • [37] N-staging of recurrent breast cancer in F-18-FDG-PET/CT
    Elgeti, F.
    Steffen, I.
    Denecke, T.
    Amthauer, H.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 : S199 - S199
  • [38] Comparison of nodal staging between CT, MRI, and [18F]-FDG PET/MRI in patients with newly diagnosed breast cancer
    Janna Morawitz
    Nils-Martin Bruckmann
    Frederic Dietzel
    Tim Ullrich
    Ann-Kathrin Bittner
    Oliver Hoffmann
    Eugen Ruckhäberle
    Svjetlana Mohrmann
    Lena Häberle
    Marc Ingenwerth
    Daniel Benjamin Abrar
    Lino Morris Sawicki
    Katharina Breuckmann
    Wolfgang Peter Fendler
    Ken Herrmann
    Christian Buchbender
    Gerald Antoch
    Lale Umutlu
    Julian Kirchner
    [J]. European Journal of Nuclear Medicine and Molecular Imaging, 2022, 49 : 992 - 1001
  • [39] 18F-FDG PET/CT for staging of penile cancer
    Scher, B
    Seitz, M
    Reiser, M
    Hungerhuber, E
    Hahn, K
    Tiling, R
    Herzog, P
    Reiser, M
    Schneede, P
    Dresel, S
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2005, 46 (09) : 1460 - 1465
  • [40] Incidental 18F-FDG-negative Breast Cancer in the Staging-18F-FDG-PET/CT in Oesophageal Carcinoma
    Hamerla, Gordian
    Meyer, Hans-Jonas
    Purz, Sandra
    Surov, Alexey
    [J]. ROFO-FORTSCHRITTE AUF DEM GEBIET DER RONTGENSTRAHLEN UND DER BILDGEBENDEN VERFAHREN, 2018, 190 (10): : 971 - +
12345